Document is current
Any future updates will be listed below
-
Authors
López Muñoz, Ana María https://orcid.org/0000-0002-5476-3957
González Flores, Encarnación
Carral Maseda, Alberto
Pimentel Cáceres, Paola
Afonso Gómez, Ruth
López López, Carlos
Jimeno Maté, Raquel
Reina Zoilo, Juan José
Castañón López, Carmen
Salgado Fernández, Mercedes
Aparicio Urtasun, Jorge
Asensio Martínez, Elena
Martín Gómez, Teresa
-
Funding
Funding for this research was provided by:
BAYER HISPANIA, SL
- License Information
-
More Information
Article History
Received: 23 May 2024
Accepted: 19 July 2024
First Online: 11 August 2024
Declarations
:
: AMLM has received honorarium for being part of advisory boards from Bayer. EGF has received honorarium for being part of advisory boards from Bayer. ACM has received honorarium for being part of advisory boards from Bayer, RAG has received honorarium for being part of advisory boards from Bayer and Servier. CLL has received honorarium for being part of advisory boards and lecturing from Bayer, Merck, Roche, Amgen, Sanofi, MSD, Pierre Fabre and Servier, JJRZ has received honorarium for being part of advisory boards from Bayer. CCL has received honorarium for being part of advisory boards from Bayer, JAU has received honorarium for being part of advisory boards from Bayer, Merck, Pierre Fabre and Servier, EAM has received honorarium for being part of advisory boards from Bayer, Servier, Merck and Amgen, TMG has received honorarium for being part of advisory boards from Bayer. PMC, RJM, MSF have no conflicts of interest.
: The study was approved by the Medicines Research Ethics Committee of Galicia (“Comité de Ética de la Investigación con Medicamentos de Galicia”, Santiago de Compostela, Spain; Register # 2021/264).
: Written informed consent was obtained according to local regulations.
: Not applicable.
